Back to Search Start Over

RANDOMIZED PHASE II TRIAL COMPARING OBINUTUZUMAB (GA101) WITH RITUXIMAB IN PATIENTS WITH RELAPSED CD20+ INDOLENT BCELL NON-HODGKIN LYMPHOMA: PRELIMINARY ANALYSIS OF THE GAUSS STUDY

Subjects

Subjects :
NON-HODGKIN’S LYMPHOMA

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od......4094..0dc710f7acb93cfc6b04f5bb369168fc